Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 8,000 Class A shares of the company on 06/12/2024, with an aggregate market value of $4,307.20. The shares were originally acquired on 10/10/2022 as part of a restricted stock vesting agreement with the issuer, as compensation. This planned sale follows a significant transaction history over the past few months, where a total of 253,952 securities were sold, amounting to gross proceeds of $227,452.20. The notice of the intended sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.

Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 8,000 Class A shares of the company on 06/12/2024, with an aggregate market value of $4,307.20. The shares were originally acquired on 10/10/2022 as part of a restricted stock vesting agreement with the issuer, as compensation. This planned sale follows a significant transaction history over the past few months, where a total of 253,952 securities were sold, amounting to gross proceeds of $227,452.20. The notice of the intended sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.